The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis

Completed 410 enrolled Shanghai Jiao Tong University School of Medicine

Non-randomizedParallel-groupOpen-labelPrevention

Summary

The aim of present study is to examine the effect of low-dose aspirin on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis.

Timeline

Start: 2008-01
Primary completion: 2014-09
Completion: 2014-09

Outcome

Missed primary endpoint

paper The cumulative survival rate was not significantly higher in the aspirin than in the nonaspirin users (log rank χ2 = 1.080, P = 0.299). PMID 26932276 ↗

Publications

Liu J, Pan Y, Chen L, Qiao QY, Wang J, Pan LH, Gu YH, Gu HF, Fu SK, Jin HM. Low-dose aspirin for prevention of cardiovascular disease in patients on hemodialysis: A 5-y prospective cohort study. Hemodial Int. 2016 Oct;20(4):548-557. doi: 10.1111/hdi.12409. Epub 2016 Mar 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aspirin	Small molecule	75 mg	Oral
Subject	Aspirin	Small molecule	100 mg	Oral

Indications

No indication recorded.